Aduro Biotech (ADRO)

[rtraster]

Better alternatives than paying 150% one day later
So at this point, you can either agree that this company is worth 150% more than it was yesterday, even though it hasn't changed whatsoever as a company, or you could look for alternatives.

Hint: Paying an extra 150% the day after an IPO is a losing strategy since 1999, learn your history lesson.

Wait. I'm following Dr. Frost into a similar company in the same space, MBVX, but even if you want to stick with Aduro then you should look into the relationship it has with other companies and Adam Feuerstein's recent commentary which is very enlightening re: another public company in this space.